Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Systemic JIA: new developments in the understanding of the pathophysiology and therapy.

Vastert SJ, Kuis W, Grom AA.

Best Pract Res Clin Rheumatol. 2009 Oct;23(5):655-64. doi: 10.1016/j.berh.2009.08.003. Review.

2.

Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.

Kumar S.

Indian J Pediatr. 2016 Apr;83(4):322-7. doi: 10.1007/s12098-016-2060-z. Epub 2016 Feb 26. Review.

PMID:
26916892
3.

Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches.

Bruck N, Schnabel A, Hedrich CM.

Clin Immunol. 2015 Jul;159(1):72-83. doi: 10.1016/j.clim.2015.04.018. Epub 2015 May 6. Review.

PMID:
25956529
4.

Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.

Woerner A, von Scheven-Gête A, Cimaz R, Hofer M.

Expert Rev Clin Immunol. 2015 May;11(5):575-88. doi: 10.1586/1744666X.2015.1032257. Epub 2015 Apr 4. Review.

PMID:
25843554
5.

Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.

Wagner-Weiner L.

Pediatr Ann. 2015 Jun;44(6):e142-7. doi: 10.3928/00904481-20150611-09. Review.

PMID:
26114369
6.

Update on the pathogenesis and treatment of systemic idiopathic arthritis.

Sikora KA, Grom AA.

Curr Opin Pediatr. 2011 Dec;23(6):640-6. doi: 10.1097/MOP.0b013e32834cba24. Review.

7.

Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.

Ravelli A, Grom AA, Behrens EM, Cron RQ.

Genes Immun. 2012 Jun;13(4):289-98. doi: 10.1038/gene.2012.3. Epub 2012 Mar 15. Review.

PMID:
22418018
8.

Systemic-onset juvenile idiopathic arthritis.

Cimaz R.

Autoimmun Rev. 2016 Sep;15(9):931-4. doi: 10.1016/j.autrev.2016.07.004. Epub 2016 Jul 6. Review.

PMID:
27392503
9.

Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.

Yokota S, Tanaka T, Kishimoto T.

Ther Adv Musculoskelet Dis. 2012 Dec;4(6):387-97. doi: 10.1177/1759720X12455960.

10.

Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.

Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P.

Rheumatology (Oxford). 2015 Aug;54(8):1507-17. doi: 10.1093/rheumatology/keu524. Epub 2015 Mar 12.

PMID:
25767156
11.

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Mellins ED, Macaubas C, Grom AA.

Nat Rev Rheumatol. 2011 Jun 7;7(7):416-26. doi: 10.1038/nrrheum.2011.68. Review.

12.

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.

Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.

Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. Epub 2016 Dec 7.

13.

Glucocorticoids in the management of systemic juvenile idiopathic arthritis.

Vannucci G, Cantarini L, Giani T, Marrani E, Moretti D, Pagnini I, Simonini G, Cimaz R.

Paediatr Drugs. 2013 Oct;15(5):343-9. doi: 10.1007/s40272-013-0038-0. Review.

PMID:
23813411
14.

Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.

Aytaç S, Batu ED, Ünal Ş, Bilginer Y, Çetin M, Tuncer M, Gümrük F, Özen S.

Rheumatol Int. 2016 Oct;36(10):1421-9. doi: 10.1007/s00296-016-3545-9. Epub 2016 Aug 10.

PMID:
27510530
15.

Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Schulert GS, Grom AA.

Annu Rev Med. 2015;66:145-59. doi: 10.1146/annurev-med-061813-012806. Epub 2014 Nov 5. Review.

PMID:
25386930
16.

Update on the medical treatment of juvenile idiopathic arthritis.

Hashkes PJ, Laxer RM.

Curr Rheumatol Rep. 2006 Dec;8(6):450-8. Review.

PMID:
17092444
17.

Macrophage activation syndrome and cytokine-directed therapies.

Schulert GS, Grom AA.

Best Pract Res Clin Rheumatol. 2014 Apr;28(2):277-92. doi: 10.1016/j.berh.2014.03.002. Review.

18.

IL-6 blockers in systemic onset juvenile idiopathic arthritis.

Barone P, Pignataro R, Garozzo MT, Leonardi S.

Immunotherapy. 2016;8(1):79-87. doi: 10.2217/imt.15.104. Epub 2015 Dec 7. Review.

PMID:
26642378
19.

Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, Caiello I, Davì S, Schulert G, Ravelli A, Grom AA, de Min C, De Benedetti F.

Ann Rheum Dis. 2017 Jan;76(1):166-172. doi: 10.1136/annrheumdis-2015-209020. Epub 2016 Jun 13.

PMID:
27296321
20.

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, Kubota T, Yamasaki Y, Takei S, Yachie A.

Clin Immunol. 2015 Oct;160(2):277-81. doi: 10.1016/j.clim.2015.06.005. Epub 2015 Jun 20.

PMID:
26101092

Supplemental Content

Support Center